Compare Prodia Diagnostic Line Tbk (PRDL) vs Tripar Multivision Plus Tbk. (RAAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prodia Diagnostic Line Tbk vs Tripar Multivision Plus Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B), while Tripar Multivision Plus Tbk. trades at Rp188 (market cap 1.28T). The key difference: Tripar Multivision Plus Tbk. is far larger — about 2.7× Prodia Diagnostic Line Tbk's market cap. Which is the better fit depends on your goals.
| PRDL | RAAM | |
|---|---|---|
Market Cap | 470.58B | 1.28T |
Indicative Equilibrium Price | 272 | 190 |
Indicative Equilibrium Volume | 415 | 66 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prodia Diagnostic Line Tbk
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →About Tripar Multivision Plus Tbk.
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →
